Literature DB >> 30536471

Mitochondrial DNA mutation m.3243A>G is associated with altered mitochondrial function in peripheral blood mononuclear cells, with heteroplasmy levels and with clinical phenotypes.

X Geng1,2,3, Y Zhang1,3,4, J Yan5,6,7, C Chu1,2,3, F Gao1,2,3, Z Jiang1,2,3, X Zhang8, Y Chen9, X Wei10, Y Feng11, H Lu1,2,3, C Wang1,2,3, F Zeng5,6,7, W Jia1,2,3.   

Abstract

AIMS: To investigate the associations among heteroplasmy levels (i.e. the proportions of mutant and wild-type mitochondrial DNA in the same cell), mitochondrial function and clinical severity of the m.3243A>G mutation.
METHODS: A total of 17 participants carrying the m.3243A>G mutation and 17 sex- and age-matched healthy controls were included in this study. Heteroplasmy levels of the m.3243A>G mutation in leukocytes, saliva and urine sediment were determined by pyrosequencing. The clinical evaluation included endocrinological, audiological and ophthalmological examinations. Mitochondrial function was determined in peripheral blood mononuclear cells isolated from participants.
RESULTS: Heteroplasmy levels in urine sediment were higher than those in leukocytes and saliva. Reduced levels of adenosine triphosphate and mitochondrial membrane potential, and increased reactive oxygen species production were observed in mutant peripheral blood mononuclear cells (all P < 0.05). Linear regression analysis indicated that higher heteroplasmy levels in peripheral blood leukocytes were associated with increased levels of glycated albumin and HbA1c , and decreased total hip bone mineral density T-score after adjustment for age and sex (all P < 0.05). Furthermore, mitochondrial membrane potential was independently associated with bone mineral density T-score at the femoral neck (P < 0.05).
CONCLUSIONS: Heteroplasmy levels in peripheral blood leukocytes and mitochondrial membrane potential in peripheral blood mononuclear cells were closely associated with clinical manifestations and were valuable for evaluation of the clinical severity of the m.3243A>G mutation.
© 2018 Diabetes UK.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30536471     DOI: 10.1111/dme.13874

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  3 in total

1.  De Novo Mutation of m.3243A>G together with m.16093T>C Associated with Atypical Clinical Features in a Pedigree with MIDD Syndrome.

Authors:  Zhixin Jiang; Yinan Zhang; Jingbin Yan; Fengwen Li; Xinqian Geng; Huijuan Lu; Xiaoer Wei; Yanmei Feng; Congrong Wang; Weiping Jia
Journal:  J Diabetes Res       Date:  2019-04-04       Impact factor: 4.011

Review 2.  Rolling-Circle Replication in Mitochondrial DNA Inheritance: Scientific Evidence and Significance from Yeast to Human Cells.

Authors:  Feng Ling; Minoru Yoshida
Journal:  Genes (Basel)       Date:  2020-05-06       Impact factor: 4.096

3.  ATF5, a putative therapeutic target for the mitochondrial DNA 3243A > G mutation-related disease.

Authors:  Xinpei Gao; Zhixin Jiang; Xinfeng Yan; Jiping Liu; Fengwen Li; Peng Liu; Jialu Li; Yuehua Wei; Yi Eve Sun; Yinan Zhang; Congrong Wang
Journal:  Cell Death Dis       Date:  2021-07-14       Impact factor: 8.469

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.